Literature DB >> 2472189

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced.

A Novelli1, J A Reilly, P G Lysko, R C Henneberry.   

Abstract

The N-methyl-D-aspartate (NMDA) subtype of glutamate receptor appears to play a pivotal role in enabling glutamate to express its neurotoxic potential in a variety of neurological disorders. Our results show that the transition of glutamate from neurotransmitter to neurotoxin is facilitated when cellular energy is limited in cultured cerebellar neurons. Omission of glucose, exclusion of oxygen, or inclusion of inhibitors of oxidative phosphorylation or of the sodium/potassium pump, enables the excitatory amino acids glutamate or NMDA to express their neurotoxic potential. We interpret these results as demonstrating that glucose metabolism, ATP production, and functioning Na+,K+-ATPases are necessary to generate a resting potential sufficient to maintain the voltage-dependent Mg2+ block of the NMDA receptor channel; relief of the Mg2+ block enables the excitatory amino acids to act persistently at the NMDA receptor, resulting in the opening of ion channels and subsequent neuronal damage. These findings are discussed in the context of perturbations or abnormalities which lead to decreased availability or utilization of glucose and oxygen in the brain which may trigger endogenous excitatory amino acids to become neurotoxic by this mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2472189     DOI: 10.1016/0006-8993(88)90765-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  138 in total

1.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Low resting potential and postnatal upregulation of NMDA receptors may cause Cajal-Retzius cell death.

Authors:  J M Mienville; C Pesold
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

3.  Altered residual ATP content in rat brain cortex subcellular fractions following status epilepticus induced by lithium and pilocarpine.

Authors:  N Y Walton; A K Nagy; D M Treiman
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

4.  Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation.

Authors:  Chris J Reisenauer; Dhaval P Bhatt; Dane J Mitteness; Evan R Slanczka; Heidi M Gienger; John A Watt; Thad A Rosenberger
Journal:  J Neurochem       Date:  2011-02-24       Impact factor: 5.372

5.  Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.

Authors:  M Li; X Wang; M K Meintzer; T Laessig; M J Birnbaum; K A Heidenreich
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 6.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

7.  Dextrorphan attenuates the behavioral consequences of ischemia and the biochemical consequences of anoxia: possible role of N-methyl-d-aspartate receptor antagonism and ATP replenishing action in its cerebroprotecting profile.

Authors:  N Himori; Y Tanaka; M Kurasawa; K Mishima; N Akaike; M Imai; K Ueno; T Matsukura; H Watanabe
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway.

Authors:  Daming Zhu; Xuan Wu; Kenneth I Strauss; Robert H Lipsky; Zehra Qureshi; Artin Terhakopian; Antonello Novelli; Krishna Banaudha; Ann M Marini
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

Review 9.  Glutamate: its role in learning, memory, and the aging brain.

Authors:  W J McEntee; T H Crook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Acetate supplementation increases brain phosphocreatine and reduces AMP levels with no effect on mitochondrial biogenesis.

Authors:  Dhaval P Bhatt; Heidi M Houdek; John A Watt; Thad A Rosenberger
Journal:  Neurochem Int       Date:  2013-01-12       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.